Glaucoma and Telemedicine

Area of Science:

• Ophthalmology
• Telemedicine
• Digital Health

Background:

• The COVID-19 pandemic accelerated the adoption of telemedicine for healthcare delivery.
• Teleglaucoma applies telemedicine to screen and monitor glaucoma, an optic neuropathy.
• It addresses distance barriers and improves access to eye care services.

Purpose of the Study:

• To highlight the role of teleglaucoma in early glaucoma detection and remote patient management.
• To discuss the potential of new technologies, including AI, in enhancing teleglaucoma accuracy.
• To identify the need for regulatory clarity and robust data systems for teleglaucoma implementation.

Main Methods:

• Utilizing telemedicine platforms for remote glaucoma screening and monitoring.
• Implementing virtual clinics with synchronous data collection by non-specialists and asynchronous review by ophthalmologists.
• Exploring the integration of artificial intelligence for improved diagnostic accuracy.

Main Results:

• Teleglaucoma facilitates early disease detection, particularly in underserved areas.
• Remote monitoring can optimize healthcare logistics, reduce consultations, and save costs for low-risk patients.
• AI integration shows promise for enhancing accuracy and supporting clinical decisions.

Conclusions:

• Teleglaucoma represents a significant advancement in managing glaucoma remotely.
• Clearer regulatory frameworks and robust data infrastructure are essential for widespread adoption.
• Continued studies are required to validate global cost-effectiveness and safety.